This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Life Technologies Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Jian Liu in AAV Vector Production
Introduction
Jian Liu is an accomplished inventor based in Carlsbad, CA (US). He has made significant contributions to the field of biotechnology, particularly in the production of adeno-associated virus (AAV) vectors. His innovative work has the potential to advance gene therapy and other medical applications.
Latest Patents
Jian Liu holds a patent for a "Suspension system for adeno associated virus production." This technology relates to a production system designed to produce AAV vectors in a serum-free suspension platform and at high titers. The system utilizes reagents that include media, cells, transfection reagents, AAV enhancers, and lysis buffers. Each component is specifically designed to maximize AAV production from the suspension culture of mammalian cells, such as HEK293 cells. With this new system, it is possible to deliver up to about 2×10 viral genomes per milliliter (vg/mL) of unconcentrated AAV vectors.
Career Highlights
Jian Liu is currently employed at Life Technologies Corporation, where he continues to develop innovative solutions in biotechnology. His work has garnered attention for its potential impact on the production of viral vectors, which are crucial for various therapeutic applications.
Collaborations
Jian Liu has collaborated with notable colleagues, including Xin Yu and Chao Yan Lin. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Jian Liu's contributions to AAV vector production exemplify the importance of innovation in biotechnology. His patented technology not only enhances production efficiency but also holds promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
